Science By Press Release

 

Pharmaceutical companies are riding the wave of stock jumps based on their own data. Some are calling this “science by press release.”

For example, Pfizer has announced that its Covid vaccine is effective in children between the ages of 5 and 11 in a second trial but the FDA has not signed off on that. Johnson & Johnson announced that a booster shot provides 94% protection against Covid but the FDA has not signed off on that either. Both companies rode a stock boost on these announcements.

“These company press releases are not intended for you or for me. They are meant for current and potential shareholders to jack up the stock. That’s the job of the company CEO,” Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine, told The Washington Post. “The problem is they are written in ways that are oblivious or tone-deaf to how the public might respond in a raging pandemic.”

It is not in our best interest to rush these studies or approvals. It is, however, in the pharma companies’ best interest and that is worth noting.

Share this article

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on whatsapp
Share on vk
Share on email
Share on reddit

Related Articles

Join the mailing list

Get the daily email that makes reading the investment news actually enjoyable.

Scroll to Top